ONZEMIPGENE PARVEC
UNII WU56BNE7AU

Substance Identification & Data

This profile provides standardized clinical and technical data for Onzemipgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WU56BNE7AU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2269489-41-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WU56BNE7AU
CAS Registry Number
2269489-41-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ONZEMIPGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C215264
National Cancer Institute reference terminology for clinical and research data.
INN ID
13190
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Onzemipgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ONZEMIPGENE PARVEC

Common Names & Synonyms

AAVCAGSCD59
ONZEMIPGENE PARVEC [INN]
RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 2 (RAAV2) VECTOR, ENCODING A TRUNCATED SOLUBLE FORM OF HUMAN CD59 (SCD59, MEMBRANE-INDEPENDENT HUMAN CD59) UNDER CONTROL OF THE CAG PROMOTER (CYTOMEGALOVIRUS (CMV) ENHANCER / CHICKEN BETAACTIN (CBA) PROMOTER / RABBIT BETA-GLOBIN ACCEPTOR CONTAINING CHIMERIC INTRON) AND A RABBIT BETA-GLOBIN POLYADENYLATION SIGNAL

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus